Capecitabine, Tucatinib, and Intrathecal Trastuzumab for Breast Cancer Patients With Leptomeningeal Disease
Capecitabine, Tucatinib, and Intrathecal Trastuzumab for Breast Cancer Patients With Leptomeningeal Disease
Recruiting · NCT05800275 · Registry updated 2025-11-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Capecitabine, Tucatinib, and Intrathecal Trastuzumab for Breast Cancer Patients With Leptomeningeal Disease | Neoplasms by Site, central nervous system cancer, neoplasm, neoplastic meningitis, nervous system disorder, tumor of meninges | Recruiting | Phase 2 | 2025-11-18 | NCT05800275 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Seagen Inc. | 31 |
| UNICANCER | 111 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre Antoine Lacassagne | Nice | France | 83 |
| Centre François Baclesse | Caen | France | 23 |
| Centre Georges-François Leclerc | Dijon | France | 15 |
| Centre Henri Becquerel | Rouen | France | 1 |
| Centre Jean Perrin | Clermont-Ferrand | France | 58 |
| Centre Léon Bérard | Lyon | France | 50 |
| Gustave Roussy | Villejuif | France | 119 |
| Institut Bergonié | Bordeaux | France | 14 |
| Institut de cancérologie Strasbourg Europe - ICANS | Strasbourg | France | 1 |
| Institut Jean Godinot | Reims | France | 10 |
| Institut Régional du Cancer de Montpellier | Montpellier | France | 14 |